|
|
Article: Increasing Cancer Rates Impel In-Vitro Diagnostics Markets in the United States.
- Article from:
- PR Newswire
- Article date:
- November 20, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PALO ALTO, Calif., Nov. 20 /PRNewswire/ -- The number of Americans suffering from cancer is escalating at a substantial rate. This is significantly increasing the demand for diagnostic tests. As the new guidelines for cancer management in the United States mandate more quantitative and non-invasive testing as part of therapeutic management, all types of cancer in-vitro diagnostic (IVD) tests are witnessing growing demand.
New analysis from Frost and Sullivan (http://www.drugdiscovery.frost.com/ ), U.S. Cancer In-Vitro Diagnostics Markets, reveals that the market accrued revenues of $881.5 million in 2005 and estimates it to reach $2.3 billion by 2012.
...